pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,157
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
NOS-01
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Nospharma
0
catalysts
Preclinical
NOVS-100
Obesity
Celloram Inc
0
catalysts
Preclinical
NP-4
Cystinosis
Nacuity Pharmaceuticals Inc
0
catalysts
Preclinical
NP-6A
Cardiomyopathy
Novopyxis Inc
← prev
page 23 of 39
next →
131
Pain
89
Neurology
1
0
catalysts
Preclinical
NP-855
Neuroblastoma
NanoPharmaceuticals LLC
0
catalysts
Preclinical
NPC-31
Neurodegenerative Diseases
Nobelpharma Co Ltd
0
catalysts
Preclinical
NRDN-101
Type 1 Diabetes (Juvenile Diabetes)
Neurodon LLC
0
catalysts
Preclinical
NS-002
Hyperammonemia
Nano Scrips
0
catalysts
Preclinical
NS-051
Duchenne Muscular Dystrophy
NS Pharma Inc
0
catalysts
Preclinical
NT-102
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Neuroene Therapeutics LLC
0
catalysts
Preclinical
NTG-101
Degenerative Disc Disease
Notogen Inc
0
catalysts
Preclinical
NTM-004
Pain
Neumentum Inc
0
catalysts
Preclinical
NTM-005
Pain
Neumentum Inc
0
catalysts
Preclinical
NTY-184
Major Depressive Disorder
Neuromity Therapeutics Inc
0
catalysts
Preclinical
NU-001
Ovarian Cancer
NUAgo Therapeutics Inc
0
catalysts
Preclinical
NU-01
Heavy Metal Poisoning
Medesis Pharma SA
0
catalysts
Preclinical
NU-02
Heavy Metal Poisoning
Medesis Pharma SA
0
catalysts
Preclinical
NV-101
Ewing Sarcoma
Oncology Pharma Inc
0
catalysts
Preclinical
NV-354
Subacute Necrotizing Encephalomyelopathy (Leigh Disease)
Abliva AB
0
catalysts
Preclinical
NV-360
Herpes Zoster (Shingles)
$NNVC
NANOVIRICIDES, INC.
0
catalysts
Preclinical
NVCov-2R
remdesivir
Coronavirus Disease 2019 (COVID-19)
$NNVC
NANOVIRICIDES, INC.
0
catalysts
Preclinical
NVK-006
Unspecified Infectious Diseases
Nevakar Injectables Inc
0
catalysts
Preclinical
NVPLC-2767
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
NVP Healthcare Co Ltd
0
catalysts
Preclinical
NVX-101
rifampicin
Age Related Macular Degeneration
NeoVascularX Inc
0
catalysts
Preclinical
Nanoapalutamide
Prostate Cancer
Nanoform Finland Plc
0
catalysts
Preclinical
Nanoparticle Mesothelin MOTO-CAR
Solid Tumor
Thunder Biotech Inc
0
catalysts
Preclinical
Nephron Progenitor Cells (Auto)
Chronic Kidney Disease (Chronic Renal Failure)
Jikei University School of Medicine
0
catalysts
Preclinical
Nephron Progenitor Cells (Organ) (Allo iPS Cell-Based Induced)
Renal Failure
Sumitomo Pharma Co Ltd
0
catalysts
Preclinical
Next-generation CAR-T
Ovarian Cancer
ToolGen Inc
0
catalysts
Preclinical
Niemann-Pick Type C
Niemann-Pick Disease Type C
U.S. National Institutes of Health
0
catalysts
